Vitamin D-Related Genes and Thyroid Cancer-A Systematic Review.

Vitamin D, formerly known for its role in calcium-phosphorus homeostasis, was shown to exert a broad influence on immunity and on differentiation and proliferation processes in the last few years. In the field of endocrinology, there is proof of the potential role of vitamin D and vitamin D-related genes in the pathogenesis of thyroid cancer-the most prevalent endocrine malignancy. Therefore, the study aimed to systematically review the publications on the association between vitamin D-related gene variants (polymorphisms, mutations, etc.) and thyroid cancer. PubMed, EMBASE, Scopus, and Web of Science electronic databases were searched for relevant studies. A total of ten studies were found that met the inclusion criteria. Six vitamin D-related genes were analyzed ( VDR -vitamin D receptor, CYP2R1 -cytochrome P450 family 2 subfamily R member 1, CYP24A1 -cytochrome P450 family 24 subfamily A member 1, CYP27B1 -cytochrome P450 family 27 subfamily B member 1, DHCR7 -7-dehydrocholesterol reductase and CUBN -cubilin). Moreover, a meta-analysis was conducted to summarize the data from the studies on VDR polymorphisms (rs2228570/ Fok I, rs1544410/ Bsm I, rs7975232/ Apa I and rs731236/ Taq I). Some associations between thyroid cancer risk ( VDR , CYP24A1 , DHCR7 ) or the clinical course of the disease ( VDR ) and vitamin D-related gene polymorphisms were described in the literature. However, these results seem inconclusive and need validation. A meta-analysis of the five studies of common VDR polymorphisms did not confirm their association with increased susceptibility to differentiated thyroid cancer. Further efforts are necessary to improve our understanding of thyroid cancer pathogenesis and implement targeted therapies for refractory cases.